Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue 1, 1998, Pages 18-24

  Bowler, John V ^a,b,c   Munoz, David G ^a,b   Merskey, Harold ^a,b   Hachinski, Vladimir ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Alzheimer's disease; Diagnostic accuracy; Necropsy; Verification bias

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CANADA; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FATALITY; HUMAN; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; PRIORITY JOURNAL;

EID: 0031971692     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.64.1.18     Document Type: Article

References (43)

1. Sulkava R, Haltia M, Paetau A, et al. Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry 1983;46:9-13.
2. Wade JPH, Mirsen T, Hachinski VC, et al. The clinical diagnosis of Alzheimer's disease. Arch Neurol 1987;44:24-9.
3. Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A. The consortium to establish a registry for Alzheimer's disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 1995;45:461-6.
4. Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol 1988;24:50-6.
5. Molsa PK, Paljarvi L, Rinne JO, Rinne UK, Sako E. Validity of clinical diagnosis in dementia: a prospective clinicopathological study. J Neurol Neurosurg Psychiatry 1985;48: 1085-90.
6. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988;38:359-64.
7. Mendez MF, Mastri AR, Sung JH, Frey WH. Clinically diagnosed Alzheimer disease: neuropathologic findings in 650 cases. Alzheimer Dis Assoc Disord 1992;6:35-43.
8. Kukull WA, Larson EB, Reifler BV, Lampe TH, Yerby MS, Hughes JP. The validity of three clinical diagnostic criteria for Alzheimer's disease. Neurology 1990;40:1364-9.
9. Becker JT, Boller F, Lopez OL, Saxton J, McGonigle KL. The natural history of Alzheimer's disease. Description of study cohort and accuracy of diagnosis. Arch Neurol 1994; 51:585-94.
10. Begg CB, Greenes RA. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 1983;39:207-15.
11. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978;299:926-30.
12. Hunink MGM, Polak JF, Barlan MM, O'Leary DH. Detection and quantification of carotid artery stenosis: efficacy of various Doppler velocity parameters. American Journal of Radiology 1993;160:619-25.
13. Morris JC, McKeel DW Jr, Fulling K, Torack RM, Berg L. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol 1988;24:17-22.
14. Helmes E, Merskey H, Fox H, Fry R, Bowler JV, Hachinski VC. Patterns of deterioration in senile dementia of the Alzheimer type. Arch Neurol 1995;52:306-10.
15. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Uarasu TB, eds. Geriatric psychiatry. A handbook for psychiatrists and primary care physicians. New York: Grune and Stratton, 1976:77-121.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed, revised. Washington, DC: American Psychiatric Association, 1980.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34: 939-44.
18. Hersch EL. Development and application of the extended scale for dementia. J Am Geriatr Soc 1979;27:348-54.
19. Helmes E, Merskey H, Hachinski VC, Wands K. An examination of psychometric properties of the extended scale for dementia in three different populations. Alzheimer Dis Assoc Disord 1992;6:236-46.
20. Lau C, Wands K, Merskey H, et al. Sensitivity and specificity of the extended scale for dementia. Arch Neurol 1988;45:849-52.
21. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
22. del Ser T, Munoz DG, Hachinski VC. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease. Neurology 1996; 46:682-6.
23. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-105.
24. Gibb WRG, Esiri MM, Lees AJ. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1985;110:1131-53.
25. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin Austen RB. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 1989;52:1236-47.
26. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
27. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119-39.
28. Forstl H, Burns A, Luthert P, Cairns N, Levy R. The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychiatry 1993;162:385-92.
29. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990;40:1-8.
30. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992;305:673-8.
31. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970;11:205-42.
32. Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 1988;51:1037-44.
33. Loeb C, Gandolfo C, Bino G. Intellectual impairment and cerebral lesions in multiple cerebral infarcts. A clinical-computed tomography study. Stroke 1988;19:560-65.
34. del Ser T, Bermejo F, Portera A, Arredondo JM, Bouras C, Constantinidis J. Vascular dementia. A clinicopathological study. J Neurol Sci 1990;96:1-17.
35. Gorelick PB, Chatterjee A, Patel D, et al. Cranial computed tomographic observations in multi-infarct dementia. A controlled study. Stroke 1992;23:804-11.
36. Liu CK, Miller BL, Cummings JL, et al. A quantitative MRI study of vascular dementia. Neurology 1992;42:138-43.
37. Corbett A, Bennett H, Kos S. Cognitive dysfunction following subcortical infarction. Arch Neurol 1994;51:999-1007.
38. Bowler JV, Eliasziw M, Steenhuis R, et al. The comparative evolution of Alzheimer's disease, vascular dementia and mixed dementia. Arch Neurol 1997;54:697-703.
39. O'Brien MD. Vascular dementia is underdiagnosed. Arch Neurol 1988;45:797-8.
40. Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J. Non-steroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 1995;45:51-5.
41. Breitner JC, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 1994;44:227-32.
42. McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996;47:425-32.
43. Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MM, Hofman A. Do non-steroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 1995;45:1441-5.